Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Short-term Investments (2016 - 2018)

Historic Short-term Investments for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 8 years, with Q4 2018 value amounting to $1.5 million.

  • Lifecore Biomedical, Inc. \De\'s Short-term Investments rose 6633.66% to $1.5 million in Q4 2018 from the same period last year, while for Nov 2018 it was $1.5 million, marking a year-over-year increase of 6633.66%. This contributed to the annual value of $1.5 million for FY2018, which is 12223.84% up from last year.
  • Lifecore Biomedical, Inc. \De\'s Short-term Investments amounted to $1.5 million in Q4 2018, which was up 6633.66% from $1.5 million recorded in Q3 2018.
  • Over the past 5 years, Lifecore Biomedical, Inc. \De\'s Short-term Investments peaked at $1.5 million during Q2 2018, and registered a low of $519000.0 during Q4 2016.
  • Moreover, its 3-year median value for Short-term Investments was $1.2 million (2017), whereas its average is $1.1 million.
  • Over the last 5 years, Lifecore Biomedical, Inc. \De\'s Short-term Investments had its largest YoY gain of 17765.15% in 2018, and its largest YoY loss of 6633.66% in 2018.
  • Quarter analysis of 3 years shows Lifecore Biomedical, Inc. \De\'s Short-term Investments stood at $519000.0 in 2016, then soared by 75.14% to $909000.0 in 2017, then soared by 66.34% to $1.5 million in 2018.
  • Its Short-term Investments stands at $1.5 million for Q4 2018, versus $1.5 million for Q3 2018 and $1.5 million for Q2 2018.